Concepedia

Henry P. Ciolino

HP

29

Publications

2.4K

Citations

22

H-Index

1992

Active since

Affiliations

National Cancer Institute(Current)

Frederick National Laboratory for Cancer Research

National Institutes of Health

Center for Cancer Research

Science Applications International Corporation (United States)

Henry P. Ciolino is an author at National Cancer Institute specializing in medicine, pharmacology, and biochemistry.

Top concepts

MedicinePharmacologyBiochemistryCell BiologyMetabolomicsOxidative StressTumor BiologyDrug DiscoveryPhysiologyBreast Cancer

Publications per year

1992–2021

29

Publications

29

Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially

Henry P. Ciolino, Phillip J. Daschner, Grace Chao Yeh · Biochemical Journal · 1999 · 356 citations · Full text

Chemoprevention Strategy, Cytochrome P450 1A1, Metabolomic Profiling +17

Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor.

Henry P. Ciolino, Phillip J. Daschner, Grace Chao Yeh · PubMed · 1998 · 285 citations

Chemoprevention Strategy, Lipid Peroxidation, Redox Biology +17

Effect of Curcumin on the Aryl Hydrocarbon Receptor and Cytochrome P450 1A1 in MCF-7 Human Breast Carcinoma Cells

Henry P. Ciolino, Phillip J. Daschner, Thomas T. Y. Wang et al. · Biochemical Pharmacology · 1998 · 238 citations

Breast Oncology, Biochemistry, Medicine +7

Inhibition of Aryl Hydrocarbon-Induced Cytochrome P-450 1A1 Enzyme Activity and CYP1A1 Expression by Resveratrol

Henry P. Ciolino, Grace Chao Yeh · Molecular Pharmacology · 1999 · 235 citations

The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor

Henry P. Ciolino, Grace Chao Yeh · British Journal of Cancer · 1999 · 152 citations · Full text

Rows per page

1–5 of 29